Elisabeth Müller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisabeth Müller has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Ingo Schäfer
Laboklin GmbH and Co. KG, Bad Kissingen
12 shared publications - Alexandra Kehl
Laboklin GmbH & Co. KG, 97688 Bad Kissingen, Germany
9 shared publications - Torsten J. Naucke
Laboklin GmbH and Co. KG, ²Kleintierpraxis Weissbach GbR, Bad Kissingen, Steina, Germany
6 shared publications - Urs Giger
Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland
6 shared publications - Ines Langbein-Detsch
Laboklin GmbH&Co.KG, Steubenstraße 4, 97688 Bad Kissingen, Germany
5 shared publications - Barbara Kohn
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, 14163 Berlin, Germany
4 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (11) , 1091
Environmental ESKAPE Organisms and Other Environmental Equine-Specific Indicator Pathogens—Are They Relevant in Equine Nosocomial Wound Infections?
Background: Multidrug-resistant organisms increasingly challenge infection prevention and control (IPC) in equine referral hospitals. Objectives: Assessment of selected environmental indicator pathogens in an equine teaching hospital and evaluation of their relevance for nosocomial wound infections. Study design: Observational study with repeated environmental sampling and retrospective evaluation of wound culture submissions. Methods: During three sampling periods (SPs), surface samples were collected across functional areas before and after routine cleaning/disinfection. Revision of the cleaning/disinfection protocols and environmental support staff feedback and training was performed between SP 1 and 2. Indicator pathogens were defined as an equine-adapted ESKAPEE-derived panel. Samples from surgical wounds were considered nosocomial if infection developed ≥3 days after hospitalisation. Results: Indicator pathogens were detected in all SPs, with the greatest frequency and diversity in SP 1. SP 1 yielded indicator pathogens in 25.7% of the 152 samples. After IPC optimisation, detection decreased in SP 2 to 11.2% of the 152 samples. In SP 3 with fewer samples (n = 42) sporadic recovery (7.1%) was observed. Contamination involved in particular high-touch surfaces and floors, and several pathogens persisted after cleaning/disinfection. Of 125 wounds, 38 met the criteria for nosocomial infection. Isolated from both, the environment and infected wounds were Streptococcus equi ssp. zooepidemicus, Staphylococcus aureus, Escherichia coli, and Enterobacter cloacae. Molecular typing was unavailable. Conclusions: Environmental equine-relevant indicator pathogens were detected across clinical areas. Some persisted after routine cleaning and/or were detected in nosocomial wound infections. Revision of cleaning/disinfection protocols with staff training was temporarily associated with reduced environmental contamination.
- 3 November 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (11) , 1091
Open AccessEnvironmental ESKAPE Organisms and Other Environmental Equine-Specific Indicator Pathogens—Are They Relevant in Equine Nosocomial Wound Infections?
Background: Multidrug-resistant organisms increasingly challenge infection prevention and control (IPC) in equine referral hospitals. Objectives: Assessment of selected environmental indicator pathogens in an equine teaching hospital and evaluation of their relevance for nosocomial wound infections. Study design: Observational study with repeated environmental sampling and retrospective evaluation of wound culture submissions. Methods: During three sampling periods (SPs), surface samples were collected across functional areas before and after routine cleaning/disinfection. Revision of the cleaning/disinfection protocols and environmental support staff feedback and training was performed between SP 1 and 2. Indicator pathogens were defined as an equine-adapted ESKAPEE-derived panel. Samples from surgical wounds were considered nosocomial if infection developed ≥3 days after hospitalisation. Results: Indicator pathogens were detected in all SPs, with the greatest frequency and diversity in SP 1. SP 1 yielded indicator pathogens in 25.7% of the 152 samples. After IPC optimisation, detection decreased in SP 2 to 11.2% of the 152 samples. In SP 3 with fewer samples (n = 42) sporadic recovery (7.1%) was observed. Contamination involved in particular high-touch surfaces and floors, and several pathogens persisted after cleaning/disinfection. Of 125 wounds, 38 met the criteria for nosocomial infection. Isolated from both, the environment and infected wounds were Streptococcus equi ssp. zooepidemicus, Staphylococcus aureus, Escherichia coli, and Enterobacter cloacae. Molecular typing was unavailable. Conclusions: Environmental equine-relevant indicator pathogens were detected across clinical areas. Some persisted after routine cleaning and/or were detected in nosocomial wound infections. Revision of cleaning/disinfection protocols with staff training was temporarily associated with reduced environmental contamination.
- Open Access
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (5)
Thymidine kinase 1 activity in serum and body cavity fluids of horses with lymphoma
Background: The accuracy of serum thymidine kinase 1 (TK1S) as a biomarker of lymphoma in horses is variable. The value of measurement in body cavity fluid (TK1F) has not been established. Hypothesis/Objectives: (1) TK1F and TK1S will be higher in horses with lymphoma compared to diseased controls (DCs); (2) TK1F will be higher than TK1S; and (3) there will be a strong correlation between both measurements. Animals: Twenty animals in the lymphoma and 31 animals with nonneoplastic, gastrointestinal/respiratory disorders in DC group. Methods: This was a cross-sectional study using prospectively collected data and samples obtained during routine diagnostic evaluation at referral hospitals. Thymidine kinase 1 was measured using chemiluminescence immunoassay and presented as median (and interquartile range). Nonparametric tests compared TK1F and TK1S between and within groups and Kendall’s Tau assessed correlation between TK1F and TK1S. Results: Median TK1F was 7.48 (2.20-48.23) U/L in horses with lymphoma vs 2.50 (0.59-4.83) U/L in the DC group (P = .007); median TK1S was 4.26 (0.46-9.37) U/L vs 0.40 (0.40-0.75) U/L (P < .001), respectively. Both biomarkers showed good discrimination (area under the curve > 0.70) between lymphoma and the DC group, with optimal cutoff values of 5.7 and 2.5 U/L, respectively. Thymidine kinase 1 activity in body cavity fluid (3.62 [0.85-9.86] U/L) was significantly higher than TK1S (0.50 [0.40-2.09] U/L; P < .001) and there was no significant correlation between them within groups. Conclusions and clinical importance: Thymidine kinase 1 activity in body cavity fluid and TK1S provide different information and should be interpreted independently. They proved useful in lymphoma diagnosis, but not as a standalone test. Abstract Translated to German: Hintergrund: Die Zuverlässigkeit der Thymidinkinase-1-Aktivität im Serum (TK1S) als Lymphom-Biomarker bei Pferden ist unterschiedlich. Die Messung in Körperhöhlenflüssigkeit (TK1F) ist noch nicht etabliert. Hypothesen/Ziele: (1) TK1F und TK1S sind bei Pferden mit Lymphom im Vergleich zu erkrankten Kontrolltieren (DC) erhöht; (2) TK1F ist höher als TK1S; (3) es besteht eine starke Korrelation zwischen beiden Biomarkern. Tiere: Zwanzig Tiere in der Lymphomgruppe und einsinddreissig Tiere mit verschiedenen nicht-neoplastischen gastrointestinalen/respiratorischen Erkrankungen in der DC-Gruppe. Methoden: Es handelte sich um eine Querschnittsstudie mit prospektiv erhobenen Daten und Proben, die im Rahmen der routinemäßigen diagnostischen Abklärung in Überweisungskliniken gewonnen wurden. TK1 wurde mittels Chemilumineszenz-Immunoassay gemessen und als Median (und Interquartilsabstand) dargestellt. Mittles nichtparametrischer Tests wurden TK1F und TK1S zwischen und innerhalb der Gruppen verglichen und Kendals Tau bewertete die Korrelation zwischen TK1F und TK1S. Ergebnisse: Der Median von TK1F betrug 7,48 (2,20-48,23) U/L bei Pferden mit Lymphom gegenüber 2,50 (0,59-4,83) U/L in der DC-Gruppe (P = 0,007) und der Medianwert für TK1S betrug 4,26 (0,46-9,37) U/L gegenüber 0,40 (0,40-0,75) U/L (P < 0,001). Beide Biomarker zeigten eine gute Unterscheidungsfähigkeit (AUC > 0,70) zwischen der Lymphom- und der DC-Gruppe, mit optimalen Cut-off-Werten von 5,7 U/L und 2,5 U/L. TK1F (3,62 (0,85-9,86) U/L) war signifikant höher als TK1S (0,50 (0,40-2,09) U/L; P < 0,001), und es gab keine signifikante Korrelation zwischen denen innerhalb der Gruppen. Schlussfolgerungen und klinische Bedeutung: TK1F und TK1S liefern unterschiedliche Informationen und sollten separat interpretiert werden. Sie waren in der Lymphomdiagnostik hilfreich, aber nicht als alleiniger Test geeignet.
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (5)
Open AccessThymidine kinase 1 activity in serum and body cavity fluids of horses with lymphoma
Background: The accuracy of serum thymidine kinase 1 (TK1S) as a biomarker of lymphoma in horses is variable. The value of measurement in body cavity fluid (TK1F) has not been established. Hypothesis/Objectives: (1) TK1F and TK1S will be higher in horses with lymphoma compared to diseased controls (DCs); (2) TK1F will be higher than TK1S; and (3) there will be a strong correlation between both measurements. Animals: Twenty animals in the lymphoma and 31 animals with nonneoplastic, gastrointestinal/respiratory disorders in DC group. Methods: This was a cross-sectional study using prospectively collected data and samples obtained during routine diagnostic evaluation at referral hospitals. Thymidine kinase 1 was measured using chemiluminescence immunoassay and presented as median (and interquartile range). Nonparametric tests compared TK1F and TK1S between and within groups and Kendall’s Tau assessed correlation between TK1F and TK1S. Results: Median TK1F was 7.48 (2.20-48.23) U/L in horses with lymphoma vs 2.50 (0.59-4.83) U/L in the DC group (P = .007); median TK1S was 4.26 (0.46-9.37) U/L vs 0.40 (0.40-0.75) U/L (P < .001), respectively. Both biomarkers showed good discrimination (area under the curve > 0.70) between lymphoma and the DC group, with optimal cutoff values of 5.7 and 2.5 U/L, respectively. Thymidine kinase 1 activity in body cavity fluid (3.62 [0.85-9.86] U/L) was significantly higher than TK1S (0.50 [0.40-2.09] U/L; P < .001) and there was no significant correlation between them within groups. Conclusions and clinical importance: Thymidine kinase 1 activity in body cavity fluid and TK1S provide different information and should be interpreted independently. They proved useful in lymphoma diagnosis, but not as a standalone test. Abstract Translated to German: Hintergrund: Die Zuverlässigkeit der Thymidinkinase-1-Aktivität im Serum (TK1S) als Lymphom-Biomarker bei Pferden ist unterschiedlich. Die Messung in Körperhöhlenflüssigkeit (TK1F) ist noch nicht etabliert. Hypothesen/Ziele: (1) TK1F und TK1S sind bei Pferden mit Lymphom im Vergleich zu erkrankten Kontrolltieren (DC) erhöht; (2) TK1F ist höher als TK1S; (3) es besteht eine starke Korrelation zwischen beiden Biomarkern. Tiere: Zwanzig Tiere in der Lymphomgruppe und einsinddreissig Tiere mit verschiedenen nicht-neoplastischen gastrointestinalen/respiratorischen Erkrankungen in der DC-Gruppe. Methoden: Es handelte sich um eine Querschnittsstudie mit prospektiv erhobenen Daten und Proben, die im Rahmen der routinemäßigen diagnostischen Abklärung in Überweisungskliniken gewonnen wurden. TK1 wurde mittels Chemilumineszenz-Immunoassay gemessen und als Median (und Interquartilsabstand) dargestellt. Mittles nichtparametrischer Tests wurden TK1F und TK1S zwischen und innerhalb der Gruppen verglichen und Kendals Tau bewertete die Korrelation zwischen TK1F und TK1S. Ergebnisse: Der Median von TK1F betrug 7,48 (2,20-48,23) U/L bei Pferden mit Lymphom gegenüber 2,50 (0,59-4,83) U/L in der DC-Gruppe (P = 0,007) und der Medianwert für TK1S betrug 4,26 (0,46-9,37) U/L gegenüber 0,40 (0,40-0,75) U/L (P < 0,001). Beide Biomarker zeigten eine gute Unterscheidungsfähigkeit (AUC > 0,70) zwischen der Lymphom- und der DC-Gruppe, mit optimalen Cut-off-Werten von 5,7 U/L und 2,5 U/L. TK1F (3,62 (0,85-9,86) U/L) war signifikant höher als TK1S (0,50 (0,40-2,09) U/L; P < 0,001), und es gab keine signifikante Korrelation zwischen denen innerhalb der Gruppen. Schlussfolgerungen und klinische Bedeutung: TK1F und TK1S liefern unterschiedliche Informationen und sollten separat interpretiert werden. Sie waren in der Lymphomdiagnostik hilfreich, aber nicht als alleiniger Test geeignet.
- Open Access
Bacterial Surface Contamination in an Equine Hospital Before and After Cleaning and Disinfection Optimization: A Longitudinal Study with Two Post-Intervention Sampling Periods
Environmental contamination represents an important risk factor for the transmission of healthcare-associated pathogens in both human and veterinary medicine. In equine hospitals, open stable environments and high patient turnover may further increase the risk of microbial spread. The aim of this study was to evaluate the hygiene status of an equine referral hospital and to assess the effect of implementing standardized cleaning and disinfection procedures combined with targeted staff training on environmental microbial burden. Surface samples were collected using agar contact plates from predefined environmental surfaces in surgical areas, examination rooms, and stable units of an equine clinic. Sampling was conducted during three investigation periods: prior to intervention, after implementation of revised cleaning protocols and staff training, and during a later follow-up assessment. Colony-forming units (CFU) were quantified and categorized into an ordinal contamination scale (0–4) to enable standardized statistical analysis. Furthermore, delta values were calculated for every sampling period, describing the reduction in the environmental microbial burden. Pre- and post-cleaning microbial burdens were compared using nonparametric statistical methods. A total of 76 locations were sampled before and after cleaning and disinfection in sampling period 1 and 2; in sampling period 3, sample collection focused on sensitive surfaces, and 21 locations were sampled. Bacterial contamination varied considerably between functional areas, with the highest baseline contamination consistently observed in stable environments. Examination and surgical areas showed heterogeneous contamination patterns, particularly on high-touch surfaces, such as keyboards, switches, and door handles. In sampling periods 1 and 2, cleaning and disinfection significantly reduced microbial burden. The delta values in sampling period 2 were significantly lower than the delta values in both sampling period 1 and sampling period 3. These findings demonstrate that environmental contamination in equine hospitals is highly variable and influenced by surface type, clinical workflow, and proximity to patients. Structured hygiene interventions, including standardized cleaning protocols and continuous staff education, can significantly improve environmental hygiene and should be integrated into infection prevention programs in veterinary clinical facilities.
Open AccessBacterial Surface Contamination in an Equine Hospital Before and After Cleaning and Disinfection Optimization: A Longitudinal Study with Two Post-Intervention Sampling Periods
Environmental contamination represents an important risk factor for the transmission of healthcare-associated pathogens in both human and veterinary medicine. In equine hospitals, open stable environments and high patient turnover may further increase the risk of microbial spread. The aim of this study was to evaluate the hygiene status of an equine referral hospital and to assess the effect of implementing standardized cleaning and disinfection procedures combined with targeted staff training on environmental microbial burden. Surface samples were collected using agar contact plates from predefined environmental surfaces in surgical areas, examination rooms, and stable units of an equine clinic. Sampling was conducted during three investigation periods: prior to intervention, after implementation of revised cleaning protocols and staff training, and during a later follow-up assessment. Colony-forming units (CFU) were quantified and categorized into an ordinal contamination scale (0–4) to enable standardized statistical analysis. Furthermore, delta values were calculated for every sampling period, describing the reduction in the environmental microbial burden. Pre- and post-cleaning microbial burdens were compared using nonparametric statistical methods. A total of 76 locations were sampled before and after cleaning and disinfection in sampling period 1 and 2; in sampling period 3, sample collection focused on sensitive surfaces, and 21 locations were sampled. Bacterial contamination varied considerably between functional areas, with the highest baseline contamination consistently observed in stable environments. Examination and surgical areas showed heterogeneous contamination patterns, particularly on high-touch surfaces, such as keyboards, switches, and door handles. In sampling periods 1 and 2, cleaning and disinfection significantly reduced microbial burden. The delta values in sampling period 2 were significantly lower than the delta values in both sampling period 1 and sampling period 3. These findings demonstrate that environmental contamination in equine hospitals is highly variable and influenced by surface type, clinical workflow, and proximity to patients. Structured hygiene interventions, including standardized cleaning protocols and continuous staff education, can significantly improve environmental hygiene and should be integrated into infection prevention programs in veterinary clinical facilities.
- Open Access
- 16 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 584
The Occurrence of Bacterial Infections in Equine Wounds and Abscesses in Horses from 2019 to 2023
Bacterial infections in equine wounds are common and can complicate treatment and healing. This five-year retrospective study examined 2844 samples from wounds and abscesses from horses in Germany (2019–2023), analyzing bacterial prevalence by care setting and geographical region. A total of 4464 bacterial isolates were identified, with β-hemolytic streptococci (20.6%), Escherichia coli (15.6%), and Staphylococcus aureus (13.0%) being the most common. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 35.9% of Staphylococcus aureus isolates. Resistance to third- and fourth-generation cephalosporins was detected in 15.2% of Escherichia coli isolates. Samples from clinics showed a significantly higher MRSA rate, while primary care samples more often contained environmental bacteria. Regional differences in pathogen prevalence and statistically significant temporal changes were observed. The results highlight the importance of continuous microbiological surveillance and underscore the need for targeted antimicrobial stewardship in veterinary facilities. These findings have implications for infection control, empirical treatment strategies, and zoonotic risk mitigation in equine medicine.
- 16 June 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 584
Open AccessThe Occurrence of Bacterial Infections in Equine Wounds and Abscesses in Horses from 2019 to 2023
Bacterial infections in equine wounds are common and can complicate treatment and healing. This five-year retrospective study examined 2844 samples from wounds and abscesses from horses in Germany (2019–2023), analyzing bacterial prevalence by care setting and geographical region. A total of 4464 bacterial isolates were identified, with β-hemolytic streptococci (20.6%), Escherichia coli (15.6%), and Staphylococcus aureus (13.0%) being the most common. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 35.9% of Staphylococcus aureus isolates. Resistance to third- and fourth-generation cephalosporins was detected in 15.2% of Escherichia coli isolates. Samples from clinics showed a significantly higher MRSA rate, while primary care samples more often contained environmental bacteria. Regional differences in pathogen prevalence and statistically significant temporal changes were observed. The results highlight the importance of continuous microbiological surveillance and underscore the need for targeted antimicrobial stewardship in veterinary facilities. These findings have implications for infection control, empirical treatment strategies, and zoonotic risk mitigation in equine medicine.
- Open Access
- 30 May 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 558
Molecular Identification and Phenotypic Antimicrobial Resistance of Acinetobacter spp. from an Equine University Clinic in Germany
Background: While equine patient-mediated introduction of A. baumannii into hospital settings has been documented, its environmental dissemination and the risk of hospital-acquired surgical site infection remain poorly understood. Objective: Therefore, this descriptive observational study examined (a) the environmental distribution of Acinetobacter spp. in an equine university hospital, (b) the impact of the implementation of new hygiene protocols, (c) the specification of resistance patterns, and (d) the evaluation of the presence of Acinetobacter spp. in hospital-acquired wound infections. Methods: During three sampling periods, environmental samples of the stables, the treatment, and surgery areas were collected before and after cleaning and disinfection. After sampling period 1 (December 2021), the cleaning routines were optimized by reviewing the cleaning and disinfection process, as well as including further surfaces in the cleaning schedule for January 2022). This was followed by a second (February 2022) and a third (June 2022) sampling period. During sampling periods 1 and 2, 76 surfaces were sampled; in sampling period 3, only 21 critical surfaces were examined. Samples were cultured on selective agar plates and incubated at 37 °C, with bacterial growth evaluated after 24–48 h. Wound swabs were enriched in broth before culturing. Bacteria were identified using MALDI-TOF mass spectrometry. During the first sampling period, antibiotic susceptibility testing was performed using broth microdilution according to CLSI-vet standards. Results: During each sampling period, Acinetobacter spp. was detected in at least one sample in each of the different areas; however, there was a reduced detection rate from sampling period 1 throughout sampling period 3. The isolates were highly resistant against beta-lactam and macrolide antibiotics but mostly sensitive to fluroquinolones (enrofloxacin, 2.2% resistance; marbofloxacin, 0.0% resistance), aminoglycosides (gentamicin, 6.5% resistance; kanamycin, 8.7% resistance), and tetracyclines. Acinetobacter spp. was not detected in surgical site infections. Conclusions: Environmental persistence of Acinetobacter spp. in an equine clinical setting does not necessarily translate into surgical site infections. Through prudent antibiotic use, the antibiotic susceptibility of the isolates may be perceived.
- 30 May 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 558
Open AccessMolecular Identification and Phenotypic Antimicrobial Resistance of Acinetobacter spp. from an Equine University Clinic in Germany
Background: While equine patient-mediated introduction of A. baumannii into hospital settings has been documented, its environmental dissemination and the risk of hospital-acquired surgical site infection remain poorly understood. Objective: Therefore, this descriptive observational study examined (a) the environmental distribution of Acinetobacter spp. in an equine university hospital, (b) the impact of the implementation of new hygiene protocols, (c) the specification of resistance patterns, and (d) the evaluation of the presence of Acinetobacter spp. in hospital-acquired wound infections. Methods: During three sampling periods, environmental samples of the stables, the treatment, and surgery areas were collected before and after cleaning and disinfection. After sampling period 1 (December 2021), the cleaning routines were optimized by reviewing the cleaning and disinfection process, as well as including further surfaces in the cleaning schedule for January 2022). This was followed by a second (February 2022) and a third (June 2022) sampling period. During sampling periods 1 and 2, 76 surfaces were sampled; in sampling period 3, only 21 critical surfaces were examined. Samples were cultured on selective agar plates and incubated at 37 °C, with bacterial growth evaluated after 24–48 h. Wound swabs were enriched in broth before culturing. Bacteria were identified using MALDI-TOF mass spectrometry. During the first sampling period, antibiotic susceptibility testing was performed using broth microdilution according to CLSI-vet standards. Results: During each sampling period, Acinetobacter spp. was detected in at least one sample in each of the different areas; however, there was a reduced detection rate from sampling period 1 throughout sampling period 3. The isolates were highly resistant against beta-lactam and macrolide antibiotics but mostly sensitive to fluroquinolones (enrofloxacin, 2.2% resistance; marbofloxacin, 0.0% resistance), aminoglycosides (gentamicin, 6.5% resistance; kanamycin, 8.7% resistance), and tetracyclines. Acinetobacter spp. was not detected in surgical site infections. Conclusions: Environmental persistence of Acinetobacter spp. in an equine clinical setting does not necessarily translate into surgical site infections. Through prudent antibiotic use, the antibiotic susceptibility of the isolates may be perceived.
- Open Access
- 17 March 2026
- Published by Springer Nature in Parasitology Research
- Vol. 125 (1) , 47
Treatment failure in a dog with acute Babesia canis infection using lower-range therapeutic doses of imidocarb dipropionate
Canine babesiosis caused by Babesia canis is considered an emerging disease in Central and Eastern European countries, including Germany. Imidocarb dipropionate is recommended for treatment of acute B. canis infections. A nine-year-old, male intact Golden Retriever living in Saxony, Germany, was presented in November 2025 due to lethargy, inappetence, vomiting, fever (39.6 °C), and darkened urine to a small animal veterinary practice. Ectoparasite prophylaxis was discontinued three months before the onset of clinical signs. An acute B. canis infection was diagnosed based on microscopic detection of large merozoites in peripheral blood smears, followed by Babesia spp. PCR and sequencing. Hematological examination revealed marked thrombocytopenia, mild non-regenerative anemia, lymphopenia, and eosinopenia. The dog remained PCR positive after two imidocarb dipropionate injections (2.0 mg/kg bodyweight and 5.0 mg/kg bodyweight s.c.), and hematological abnormalities were still present. Prednisolone (2.0 mg/kg bodyweight s.c., continued orally) was applied, after which merozoites were still detected in peripheral blood smear analysis, so prednisolone was discontinued. After two further imidocarb dipropionate injections (9.4 mg/kg bodyweight s.c. each), the dog presented as clinically healthy, and a subsequent PCR testing was negative. From this report, different measures for dogs suffering from an acute B. canis infections can be derived: Dogs should be treated with a high dosage of imidocarb dipropionate of 6.6 mg/kg bodyweight as approved by the FDA, and the treatment success should be monitored by PCR 14 days post treatment. If treatment fails after two administrations at either dose of imidocarb dipropionate, i.e. if PCR remains positive, it is recommended to verify a B. canis infection by molecular species differentiation, e.g. via sequencing. Furthermore, dogs with treatment failure should be screened for coinfections and underlying comorbidities, which may complicate the course of an acute B. canis infection. Due to the authors’ personal experience, application of corticosteroids, even in non-immunosuppressive dosages, should be avoided, especially if blood transfusions are not necessary and/or marked hemolytic anemia is absent. Furthermore, this report highlights the importance of efficient year-round tick control, even in winter months.
- 17 March 2026
- Published by Springer Nature in Parasitology Research
- Vol. 125 (1) , 47
Open AccessTreatment failure in a dog with acute Babesia canis infection using lower-range therapeutic doses of imidocarb dipropionate
Canine babesiosis caused by Babesia canis is considered an emerging disease in Central and Eastern European countries, including Germany. Imidocarb dipropionate is recommended for treatment of acute B. canis infections. A nine-year-old, male intact Golden Retriever living in Saxony, Germany, was presented in November 2025 due to lethargy, inappetence, vomiting, fever (39.6 °C), and darkened urine to a small animal veterinary practice. Ectoparasite prophylaxis was discontinued three months before the onset of clinical signs. An acute B. canis infection was diagnosed based on microscopic detection of large merozoites in peripheral blood smears, followed by Babesia spp. PCR and sequencing. Hematological examination revealed marked thrombocytopenia, mild non-regenerative anemia, lymphopenia, and eosinopenia. The dog remained PCR positive after two imidocarb dipropionate injections (2.0 mg/kg bodyweight and 5.0 mg/kg bodyweight s.c.), and hematological abnormalities were still present. Prednisolone (2.0 mg/kg bodyweight s.c., continued orally) was applied, after which merozoites were still detected in peripheral blood smear analysis, so prednisolone was discontinued. After two further imidocarb dipropionate injections (9.4 mg/kg bodyweight s.c. each), the dog presented as clinically healthy, and a subsequent PCR testing was negative. From this report, different measures for dogs suffering from an acute B. canis infections can be derived: Dogs should be treated with a high dosage of imidocarb dipropionate of 6.6 mg/kg bodyweight as approved by the FDA, and the treatment success should be monitored by PCR 14 days post treatment. If treatment fails after two administrations at either dose of imidocarb dipropionate, i.e. if PCR remains positive, it is recommended to verify a B. canis infection by molecular species differentiation, e.g. via sequencing. Furthermore, dogs with treatment failure should be screened for coinfections and underlying comorbidities, which may complicate the course of an acute B. canis infection. Due to the authors’ personal experience, application of corticosteroids, even in non-immunosuppressive dosages, should be avoided, especially if blood transfusions are not necessary and/or marked hemolytic anemia is absent. Furthermore, this report highlights the importance of efficient year-round tick control, even in winter months.
- Open Access
- 22 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 111
Cystinuria in an Australian Cattle Dog Family—A Seemingly Androgen-Associated Autosomal Dominant Trait
In Australian Cattle Dogs (AUCDs), cystinuria was reported to be an autosomal dominant trait caused by a 6 bp deletion in the SLC3A1 gene (type II-A). Here we report an androgen association in this breed. A family of 11 adult AUCDs (five intact and one neutered male and five females) was genotyped for the SLC3A1 c.1095_1100del variant, and urine was examined for concentrations of cystine, ornithine, lysine, and arginine (COLA). Among this family, three males and five females tested heterozygous for the mutation, while all other AUCDs were homozygous for the wild-type allele. The two heterozygous intact males had severe COLA-uria, which decreased markedly after castration. Neither the third heterozygous male with a history of cystine calculi but already castrated nor the five heterozygous females exhibited increased COLA-uria. Heterozygosity for the 6 bp deletion in the SLC3A1 gene was associated with cystinuria in intact male AUCDs, but not in females. Castration of the heterozygous males reduced the cystinuria. Either the type II-A cystinuria in the AUCDs is an androgen-associated dominant trait, or this family also has another type III (androgen-dependent) cystinuria. Larger surveys are needed to further define the type(s) of cystinuria and effects of castration in AUCDs.
- 22 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 111
Open AccessCystinuria in an Australian Cattle Dog Family—A Seemingly Androgen-Associated Autosomal Dominant Trait
In Australian Cattle Dogs (AUCDs), cystinuria was reported to be an autosomal dominant trait caused by a 6 bp deletion in the SLC3A1 gene (type II-A). Here we report an androgen association in this breed. A family of 11 adult AUCDs (five intact and one neutered male and five females) was genotyped for the SLC3A1 c.1095_1100del variant, and urine was examined for concentrations of cystine, ornithine, lysine, and arginine (COLA). Among this family, three males and five females tested heterozygous for the mutation, while all other AUCDs were homozygous for the wild-type allele. The two heterozygous intact males had severe COLA-uria, which decreased markedly after castration. Neither the third heterozygous male with a history of cystine calculi but already castrated nor the five heterozygous females exhibited increased COLA-uria. Heterozygosity for the 6 bp deletion in the SLC3A1 gene was associated with cystinuria in intact male AUCDs, but not in females. Castration of the heterozygous males reduced the cystinuria. Either the type II-A cystinuria in the AUCDs is an androgen-associated dominant trait, or this family also has another type III (androgen-dependent) cystinuria. Larger surveys are needed to further define the type(s) of cystinuria and effects of castration in AUCDs.
- Open Access
Identifying Infectious Agents in Snakes (Boidae and Pythonidae) with and Without Respiratory Disease
Mycoplasmas are known respiratory pathogens in tortoises, but few studies exist in snakes. To better understand the correlation with clinical signs and co-infections, samples from mycoplasma-positive snakes with and without clinical respiratory disease were analyzed. Oral swabs from 15 snakes (pythons n = 12, boas n = 3) were examined using polymerase chain reaction (PCR) and third-generation sequencing (TGS). Additionally, mycoplasma isolation assays were performed. Pathogens detected by PCR included Mycoplasmas (15/15, 100%), serpentoviruses (9/15, 60%), and Chlamydia sp. (2/15, 13%); those detected by TGS included Mycoplasmas (14/15, 93%), serpentoviruses (10/15, 67%), Chlamydia sp. (1/15, 7%), and 15 different bacterial species. Sequencing of the mycoplasma PCR products revealed a close genetic relationship to Mycoplasmopsis agassizii. TGS identified genetically distinct mycoplasmas and three different serpentoviruses. While mycoplasmas could not be successfully propagated, Brucella intermedia comb. nov. was identified in eight cultures. Respiratory disease in snakes is often multifactorial, involving various pathogens and environmental influences. This study demonstrates that comprehensive diagnostics are essential for understanding disease processes in snakes and improving the detection of diverse pathogens. Further research is needed to improve laboratory diagnostics for infectious diseases in reptiles and to better understand the roles of various pathogens in respiratory diseases in snakes.
Open AccessIdentifying Infectious Agents in Snakes (Boidae and Pythonidae) with and Without Respiratory Disease
Mycoplasmas are known respiratory pathogens in tortoises, but few studies exist in snakes. To better understand the correlation with clinical signs and co-infections, samples from mycoplasma-positive snakes with and without clinical respiratory disease were analyzed. Oral swabs from 15 snakes (pythons n = 12, boas n = 3) were examined using polymerase chain reaction (PCR) and third-generation sequencing (TGS). Additionally, mycoplasma isolation assays were performed. Pathogens detected by PCR included Mycoplasmas (15/15, 100%), serpentoviruses (9/15, 60%), and Chlamydia sp. (2/15, 13%); those detected by TGS included Mycoplasmas (14/15, 93%), serpentoviruses (10/15, 67%), Chlamydia sp. (1/15, 7%), and 15 different bacterial species. Sequencing of the mycoplasma PCR products revealed a close genetic relationship to Mycoplasmopsis agassizii. TGS identified genetically distinct mycoplasmas and three different serpentoviruses. While mycoplasmas could not be successfully propagated, Brucella intermedia comb. nov. was identified in eight cultures. Respiratory disease in snakes is often multifactorial, involving various pathogens and environmental influences. This study demonstrates that comprehensive diagnostics are essential for understanding disease processes in snakes and improving the detection of diverse pathogens. Further research is needed to improve laboratory diagnostics for infectious diseases in reptiles and to better understand the roles of various pathogens in respiratory diseases in snakes.
- Open Access
- 7 June 2025
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 93, 106956
Reverse triiodothyronine concentrations in hyperthyroid, healthy, and azotemic cats determined by ultra-performance liquid chromatography-tandem mass spectrometry
- 7 June 2025
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 93, 106956
Open AccessReverse triiodothyronine concentrations in hyperthyroid, healthy, and azotemic cats determined by ultra-performance liquid chromatography-tandem mass spectrometry
- Open Access
- 16 December 2024
- Published by Springer Nature in Parasites & Vectors
- Vol. 17 (1) , 506
Evidence for in vivo resistance against allopurinol in a dog infected with Leishmania infantum by reduction in copy numbers of the S-adenosylmethionine synthetase (METK) gene
Background: In Europe, canine leishmaniasis is commonly caused by Leishmania infantum. Allopurinol is the main drug for long-term management of the disease, and clinical relapses of L. infantum infection treated with this drug are described. Resistance to allopurinol has been demonstrated in-vitro, but there is only little knowledge on in vivo resistance in dogs. Findings: A two-year-old female spayed Akita Inu that was adopted from a breeding facility near Nice in France was initially diagnosed with primary immune-mediated hemolytic anemia. Immunosuppressive treatment was initiated, and the dog was referred for a second opinion to the Clinique Veterinaire Alliance in France. PCR testing for L. infantum was performed out of EDTA blood and IFA as well as ELISA testing out of serum. Resistance to allopurinol was associated with chromosome and gene copy number (CN) variations including a decrease in the S-adenosylmethionine synthetase (METK) gene CN. Results: The dog showed pale mucous membranes, fever (39.1 °C), and a relapse of the anemia. The diagnosis of leishmaniasis was based on the cytological finding of Leishmania amastigotes (bone marrow, spleen, liver), positive PCR testing, and positive IFAT serology. The dog was treated with allopurinol over a period of 1316 days and additionally received two cycles of Glucantime® (meglumine antimoniate), before samples were submitted to the LABOKLIN laboratory to test for resistance against allopurinol. The laboratory work-up revealed mild thrombocytopenia, mild hyperproteinemia with hyperglobulinemia, a marked elevation of the c-reactive protein, and decreased iron concentration. Serum protein electrophoresis showed a polyclonal peak in the gamma globulins. Serology was positive in both ELISA (21.5 LE) and IFAT (1:1024). Quantitative PCR testing of blood was positive with low numbers of Leishmania (10/ml blood) at the timepoint of suspicion for resistance. The urinary protein-to-creatinine ratio was markedly elevated (2.5) and xanthine crystalluria was detected. A CN level of below 3 is considered suspicious for resistance, as revealed in the described Akita Inu dog. Conclusions: Relapse of L. infantum infection after applying allopurinol for 1316 days due to resistance was suspected clinically. Positive PCR testing, consistent hematological and biochemistry abnormalities, and reduction in the METK gene CN backed up the clinical suspicion of resistance. Dogs infected with allopurinol resistant strains of L. infantum may represent a great risk for infection of naïve dogs, cats, and humans. Graphical
- 16 December 2024
- Published by Springer Nature in Parasites & Vectors
- Vol. 17 (1) , 506
Open AccessEvidence for in vivo resistance against allopurinol in a dog infected with Leishmania infantum by reduction in copy numbers of the S-adenosylmethionine synthetase (METK) gene
Background: In Europe, canine leishmaniasis is commonly caused by Leishmania infantum. Allopurinol is the main drug for long-term management of the disease, and clinical relapses of L. infantum infection treated with this drug are described. Resistance to allopurinol has been demonstrated in-vitro, but there is only little knowledge on in vivo resistance in dogs. Findings: A two-year-old female spayed Akita Inu that was adopted from a breeding facility near Nice in France was initially diagnosed with primary immune-mediated hemolytic anemia. Immunosuppressive treatment was initiated, and the dog was referred for a second opinion to the Clinique Veterinaire Alliance in France. PCR testing for L. infantum was performed out of EDTA blood and IFA as well as ELISA testing out of serum. Resistance to allopurinol was associated with chromosome and gene copy number (CN) variations including a decrease in the S-adenosylmethionine synthetase (METK) gene CN. Results: The dog showed pale mucous membranes, fever (39.1 °C), and a relapse of the anemia. The diagnosis of leishmaniasis was based on the cytological finding of Leishmania amastigotes (bone marrow, spleen, liver), positive PCR testing, and positive IFAT serology. The dog was treated with allopurinol over a period of 1316 days and additionally received two cycles of Glucantime® (meglumine antimoniate), before samples were submitted to the LABOKLIN laboratory to test for resistance against allopurinol. The laboratory work-up revealed mild thrombocytopenia, mild hyperproteinemia with hyperglobulinemia, a marked elevation of the c-reactive protein, and decreased iron concentration. Serum protein electrophoresis showed a polyclonal peak in the gamma globulins. Serology was positive in both ELISA (21.5 LE) and IFAT (1:1024). Quantitative PCR testing of blood was positive with low numbers of Leishmania (10/ml blood) at the timepoint of suspicion for resistance. The urinary protein-to-creatinine ratio was markedly elevated (2.5) and xanthine crystalluria was detected. A CN level of below 3 is considered suspicious for resistance, as revealed in the described Akita Inu dog. Conclusions: Relapse of L. infantum infection after applying allopurinol for 1316 days due to resistance was suspected clinically. Positive PCR testing, consistent hematological and biochemistry abnormalities, and reduction in the METK gene CN backed up the clinical suspicion of resistance. Dogs infected with allopurinol resistant strains of L. infantum may represent a great risk for infection of naïve dogs, cats, and humans. Graphical